Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ Investing
3 ASX shares for low-risk investors
⏸️ Investing
Is it too late to buy shares in TPG Telecom Ltd, Cochlear Limited and Challenger Ltd?
⏸️ Investing
Is there a bubble in healthcare shares like Cochlear Limited?
⏸️ Investing
How much higher can Cochlear Limited and CSL Limited shares go?
⏸️ Investing
Why the Australian dollar could fall to just US50 cents
⏸️ Investing
The 3 best healthcare companies to buy today
⏸️ Investing
S&P/ASX 200 set to open lower:7 shares to watch
⏸️ Investing
3 healthcare shares every investor needs to know about
⏸️ Investing
Is there still value in CSL Limited, Cochlear Limited or Fisher & Paykel Healthcare Corp Ltd?
⏸️ Investing
The ASX's 2 best manufacturers: Cochlear Limited and CSL Limited
⏸️ Investing
4 high-yield dividend shares for 1% interest rates
⏸️ Investing
3 ASX shares that will win from a weak Australian dollar
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
